(Q36070548)

12 August 2017

sRAGE in diabetic and non-diabetic critically ill patients: effects of intensive insulin therapy (English)

1 reference

12 August 2017

1 reference

Yaseen M Arabi

1

1 reference

12 August 2017

Mohammed Dehbi

2

1 reference

12 August 2017

Asgar H Rishu

3

1 reference

12 August 2017

Engin Baturcam

4

1 reference

12 August 2017

Salim H Kahoul

5

1 reference

12 August 2017

Riette J Brits

6

1 reference

12 August 2017

Brintha Naidu

7

1 reference

12 August 2017

Abderrezak Bouchama

8

1 reference

12 August 2017

26 August 2011

1 reference

12 August 2017

1 reference

12 August 2017

15

1 reference

12 August 2017

4

1 reference

12 August 2017

R203

1 reference

Early release of soluble receptor for advanced glycation endproducts after severe trauma in humans.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Adenosine infusion attenuates soluble RAGE in endotoxin-induced inflammation in human volunteers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

RAGE: exacting a toll on the host in response to polymicrobial sepsis and Listeria monocytogenes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Intensive insulin therapy in the medical ICU.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Intensive insulin therapy protects the endothelium of critically ill patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Intensive insulin therapy in critically ill patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Prediction of creatinine clearance from serum creatinine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients

11 July 2018

1 reference

Blood glucose concentration and outcome of critical illness: the impact of diabetes

21 January 2018

1 reference

Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients.

21 January 2018

1 reference

Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension

21 January 2018

1 reference

Soluble receptor for advanced glycation end products in patients with decreased renal function.

21 January 2018

1 reference

Enhanced expression of receptor for advanced glycation end products in chronic kidney disease

21 January 2018

1 reference

Intensive versus conventional glucose control in critically ill patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Identification, classification, and expression of RAGE gene splice variants

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387645

Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE

23 September 2018

1 reference

12 December 2020

The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock

1 reference

12 December 2020

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) may reflect tissue RAGE expression in diabetes

1 reference

12 December 2020

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects

1 reference

12 December 2020

sRAGE is elevated in septic patients and associated with patients outcome

1 reference

12 December 2020

Identifiers

DOI

10.1186/CC10420

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

21871056

1 reference